Chagas Disease in Multitransfused Patients in Brazil
Author Information
Author(s): De Paula Erich V, Goncales Neiva SL, Xueref Serge, Addas-Carvalho Marcelo, Gilli Simone CO, Angerami Rodrigo N, Goncales Fernando L Jr
Primary Institution: Hematology and Hemotherapy Center, State University of Campinas, Campinas – SP, Brazil
Hypothesis
What is the prevalence of Chagas disease among multitransfused patients in Brazil?
Conclusion
The study found that measures to control Chagas disease significantly reduced its transmission through blood transfusions in Brazil.
Supporting Evidence
- The study included 351 patients who received a median of 51 blood units each.
- No cases of transfusion-transmitted Chagas disease were found among patients transfused after 1997.
- The prevalence of Chagas disease among patients transfused before 1997 was 1.30%.
Takeaway
This study shows that after Brazil started screening blood donations for Chagas disease, fewer patients got the disease from blood transfusions.
Methodology
An observational cross-sectional study was conducted with 351 multitransfused patients to assess the prevalence of Chagas disease.
Potential Biases
Potential bias from excluding patients with known Chagas disease prior to transfusion.
Limitations
The results may not be generalizable to all of Brazil due to regional differences in prevalence and transmission patterns.
Participant Demographics
{"age_mean":36,"sex_distribution":{"male":56.7,"female":43.3},"diagnosis_distribution":{"haemophilia":8.0,"haemoglobinopathies":27.6,"onco-haematological disease":52.4,"acute blood loss":5.4,"haemodialysis":6.6}}
Statistical Information
P-Value
0.75
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website